Treating uncomplicated acute UTI is a very different story. If you present with symptoms of a UTI, treatment will most likely be empirical (experimental) short course, first-line antibiotics, such as trimethoprim 300 mg orally at night for three days or cephalexin 500 mg orally twice daily for five days. However, research has found that between 20–30 percent of patients will fail this treatment1 and will go on to develop complications of an embedded infection. There are currently no treatment guidelines for the sub-group of patients who do not fully respond to standard UTI therapy.
For someone in Australia with recurrent UTI (that test positive using standard cultures), existing treatment guidelines include a trial of long-term prophylaxis (low-dose antibiotics to prevent further infections), self-start therapy or post-intercourse prophylaxis2.
In the United Kingdom and the United States, patients diagnosed with Chronic UTI (by practitioners specially trained in diagnosing and treating the complex condition), are treated with long term, full dose, first-generation antibiotics. Due to the nature of the infection (with the bacteria embedded between and within bladder wall cells) the microbes causing the infection can remain safe from antibiotic or immune attack for long periods of time. It is when they become active—usually when the cells they are hiding in slowly shed into the urine—that the antibiotic effectively eradicates them. This is why the antibiotic treatment protocol for Chronic UTI requires a constant level of antibiotics in the urine, over a lengthy period of time. This prevents active bacteria from escaping and reinfecting and colonising new cells in the bladder/urethral lining.
The treatment period for Chronic UTI is individual and varies from patient to patient. If patients receive a diagnosis and treatment for Chronic UTI early into the infection, treatment is usually complete within 6–12 months. However, by the time of diagnosis the majority of patients have suffered a chronic infection for an average of six and a half years, so the infection is more complex and treatment can sometimes take longer.
Visit our Chronic UTI Practitioner page for contacts details of practitioners specialising in treating chronic UTI.
Here is another resource listing chronic UTI practitioners based in the UK and US only.
Melbourne’s Associate Professor Patrick Charles is an Infectious Disease specialist treating patients with frequent recurrent UTIs using urinary bacteriotherapy. This involves colonising the bladder with ‘good’ bacteria to prevent ‘bad’ bacteria from taking over and causing symptoms.
The bacterial solution is instilled direct into the bladder through a catheter over three consecutive days. Each procedure is brief and the solution needs to remain in the bladder for several hours before voiding. It does not require hospitilisation.
Urinary bacteriotherapy works best for people with frequent recurrent UTIs just involving the bladder. It is not suited for infections involving the kidneys, infections caused by stents, catheters or kidney stones, people with low immune function or people taking antibiotics.
For more information about urinary bacteriotherapy, you can make contact with the Melbourne team through the Austin Health Infectious Disease Department website.
Some patients will pursue alternative treatments for their Chronic UTI for a variety of reasons. They may not have access to a diagnosis or antibiotic treatment; some may not be able to tolerate antibiotics; or others simply prefer to follow a more natural treatment path. Popular alternative treatments reported by patients include natural products like D-Mannose and Uva Ursi, other natural antimicrobials (ie Allicin, Oil of Oregano, Colloidal Silver), Chinese medicine, ozone therapy and considerable diet changes.
Success using alternative treatments varies between individuals and often involves trial and error. It is extremely common to find what works for one person might not work for the next. Reported success is based on anecdotal evidence, so exploring this treatment approach requires good research and communication with others who have successfully treated their own chronic infections. One point to make is when you find the right treatment approach for you, it is important to realise that due to the nature of the embedded infection, any treatment is going to take a considerable amount of time and you need to be patient and persistent.
Please visit the blog to read stories from others who have successfully cured their chronic UTI using long-term antibiotic therapy, alternative anti-microbials, Traditional Chinese Medicine and diet changes (including fasting).
Many people find the natural supplement D-Mannose provides relief from some UTI symptoms. D-Mannose is a naturally occurring sugar found in some foods, but the supplement form is sourced from trees such as the birch. Mannose is found throughout the human body, and, in particular, in the cells lining the bladder wall. Free floating bacteria, such as E. coli, will attach to the D-Mannose that has made its way to your bladder and are then flushed out when you empty. The Sweet Cures website gives recommendations on how to dose D-Mannose to treat UTIs and also as a preventative. For instructions, click here and scroll down to the heading ‘How to take D-Mannose’.
This 2014 study showed that D-Mannose worked effectively over six months as a prophylactic (prevention treatment) alternative to antibiotics to stop recurrent UTIs https://www.ncbi.nlm.nih.gov/pubmed/23633128
Professor Scott Hultgren’s research team at Washington University School of Medicine in St. Louis, USA, is working on a mannose UTI treatment that is many times more powerful than D-Mannose. His team has “chemically modified mannose to create a group of molecules, called mannosides, that are similar to mannose but changed in a way that the bacteria latch onto them more tightly with their pili. Unlike mannose receptors, though, these mannosides are not attached to the bladder wall, so bacteria that take hold of mannosides instead of mannose receptors are flushed out with urine’.
Read this article to learn more https://medicine.wustl.edu/news/uti-treatment-lowers-numbers-gut-e-coli-may-offer-alternative-antibiotics/
Patients have found Uva Ursi to be helpful in treating UTI symptoms. The leaves of the evergreen Uva Ursi shrub (also referred to as Bearberry) are said to have been used by Native American Indians to treat urinary infections. Uva Ursi contains a number of chemicals and tannins that are effective in reducing inflammation and fighting infection. Uva Ursi is recommended for short-term use only and comes with some strong precautions and possible interactions. Like all potential treatments, Uva Ursi should be researched thoroughly and discussed with your healthcare practitioner to see if it is a right fit for you.
Watch this video testimonial from one Australian who shares how she cured her chronic UTI by treating herself over a period of time with a combination of D-Mannose and Uva Ursi
Tradition Chinese Medicine (TCM)
There are anecdotal reports of people curing their Chronic UTI using Chinese medicine, independently or in combination with mainstream antibiotics. In 2017 a London TCM practitioner ran a small trial treating people with recurrent/chronic UTI with Chinese herbal medicine. The results of the trial are not yet available, however a number of people have so far reported having ‘good’ to ‘excellent’ results. If you can access a good TCM practitioner locally, Andrew Flower of London will email them the formula used in the trial. You can contact Andrew Flower by emailing: email@example.com
The University College London’s (UCL) Chronic UTI Research Group is involved in developing an innovative new treatment for Chronic UTI that will put an end to the use of long-term, oral antibiotics. The technology involves filling micro-bubbles with high-dose antibiotics which are delivered directly into the bladder where they can penetrate the bladder wall. Once in place, the bubbles are activated and antibiotics are released at the source of the infection where they can eradicate the intracellular bacterial reservoirs. This exciting new technology has the potential to be used to treat a wide range of serious conditions, with clinical trials for Chronic UTI to take place first in early 2018. The Atocap website states the following about Chronic UTI:
“AtoCap’s development of penetrating nano-or microcapsules may offer a solution to all of these problems – introduced directly into the bladder in a simple, painless outpatient procedure. It offers a unique way to repurpose already-approved therapeutics for a renewed utility.”
More information about micro-bubble treatment can be found at: http://atocap.com/
The following Youtube video features Eleanor Stride, Professor of Engineering at Oxford University and joint Founder of Atocap. Professor Stride explains how microbubble technology works as a targeted drug delivery system and the exciting potential of this treatment beyond treating Chronic UTI.